Post by HAS Healthcare Advanced Synthesis SA

HAS Healthcare Advanced Synthesis SA Group is accelerating its growth with a five‑year investment plan to expand CDMO capacity and strengthen HPAPI and ADC manufacturing. Key upgrades include two new 500L ADC conjugation lines (2026 and 2028) and continued expansion at our Biasca site. We’ve also added 30+ new experts to support this next phase. #investmentplan2026 #hasgroup #hashealthcareadvancedsynthesis #cerbiospharma For more information: https://lnkd.in/e-yVZe3p